TOBAM’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-362,069
Closed -$3.78M 396
2023
Q4
$3.78M Sell
362,069
-23,827
-6% -$222K 0.33% 59
2023
Q3
$3.94M Buy
385,896
+382,559
+11,464% +$3.56M 0.32% 60
2023
Q2
$25K Buy
+3,337
New +$27.1K ﹤0.01% 358
2020
Q2
Sell
-102,004
Closed -$916K 169
2020
Q1
$916K Buy
+102,004
New +$1.05M 0.07% 103
2018
Q4
Sell
-127,176
Closed -$2.74M 168
2018
Q3
$2.74M Sell
127,176
-249,451
-66% -$5.79M 0.12% 110
2018
Q2
$9.16M Sell
376,627
-123,881
-25% -$2.53M 0.38% 75
2018
Q1
$8.55M Sell
500,508
-371,099
-43% -$7.25M 0.35% 80
2017
Q4
$16.5M Buy
871,607
+348,762
+67% +$5.25M 0.71% 58
2017
Q3
$9.2M Buy
522,845
+143,497
+38% +$3.23M 0.35% 75
2017
Q2
$12.6M Sell
379,348
-245,966
-39% -$7.61M 0.47% 62
2017
Q1
$20.1M Buy
625,314
+159,218
+34% +$5.43M 0.77% 48
2016
Q4
$16.9M Sell
466,096
-78,726
-14% -$3.14M 0.69% 52
2016
Q3
$25.1M Sell
544,822
-210,025
-28% -$11M 0.9% 45
2016
Q2
$37.9M Buy
754,847
+174,101
+30% +$9.27M 1.52% 30
2016
Q1
$31.1M Buy
580,746
+351,854
+154% +$20.6M 1.22% 32
2015
Q4
$15M Buy
+228,892
New +$14.1M 0.65% 52

Other funds holding TEVA